Ardent Health Partners Statistics
Share Statistics
Ardent Health Partners has 142.73M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 142.73M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 1.01K |
| FTD / Avg. Volume | 0.4% |
Short Selling Information
The latest short interest is 1.22M, so 0.86% of the outstanding shares have been sold short.
| Short Interest | 1.22M |
| Short % of Shares Out | 0.86% |
| Short % of Float | 5.34% |
| Short Ratio (days to cover) | 5.27 |
Valuation Ratios
The PE ratio is 45.75 and the forward PE ratio is 8.57. Ardent Health Partners's PEG ratio is 0.08.
| PE Ratio | 45.75 |
| Forward PE | 8.57 |
| PS Ratio | 0.43 |
| Forward PS | 0.3 |
| PB Ratio | 3.43 |
| P/FCF Ratio | 27.3 |
| PEG Ratio | 0.08 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ardent Health Partners.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 1.75.
| Current Ratio | 1.63 |
| Quick Ratio | 1.52 |
| Debt / Equity | 1.75 |
| Total Debt / Capitalization | 63.58 |
| Cash Flow / Debt | 0.19 |
| Interest Coverage | 3.51 |
Financial Efficiency
Return on equity (ROE) is 0.07% and return on capital (ROIC) is 5.61%.
| Return on Equity (ROE) | 0.07% |
| Return on Assets (ROA) | 0.01% |
| Return on Capital (ROIC) | 5.61% |
| Revenue Per Employee | 293.99K |
| Profits Per Employee | 2.73K |
| Employee Count | 18.40K |
| Asset Turnover | 1.14 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | 22.64M |
| Effective Tax Rate | 0.15 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Ardent Health Partners's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 16.56 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 31.1 |
| Average Volume (20 Days) | 251.05K |
Income Statement
In the last 12 months, Ardent Health Partners had revenue of 5.41B and earned 50.29M in profits. Earnings per share was 0.35.
| Revenue | 5.41B |
| Gross Profit | 5.27B |
| Operating Income | 229.50M |
| Net Income | 50.29M |
| EBITDA | 350.00M |
| EBIT | 229.50M |
| Earnings Per Share (EPS) | 0.35 |
Balance Sheet
The company has 437.58M in cash and 2.40B in debt, giving a net cash position of -1.96B.
| Cash & Cash Equivalents | 437.58M |
| Total Debt | 2.40B |
| Net Cash | -1.96B |
| Retained Earnings | 155.45M |
| Total Assets | 4.80B |
| Working Capital | 803.36M |
Cash Flow
In the last 12 months, operating cash flow was 221.70M and capital expenditures -137.41M, giving a free cash flow of 84.29M.
| Operating Cash Flow | 221.70M |
| Capital Expenditures | -137.41M |
| Free Cash Flow | 84.29M |
| FCF Per Share | 0.59 |
Margins
Gross margin is 97.4%, with operating and profit margins of 4.24% and 0.93%.
| Gross Margin | 97.4% |
| Operating Margin | 4.24% |
| Pretax Margin | 2.8% |
| Profit Margin | 0.93% |
| EBITDA Margin | 6.47% |
| EBIT Margin | 4.24% |
| FCF Margin | 1.56% |
Dividends & Yields
ARDT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2.49% |
| FCF Yield | 4.21% |
Analyst Forecast
The average price target for ARDT is $22, which is 56.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $22 |
| Price Target Difference | 56.7% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Scores
| Altman Z-Score | 2.05 |
| Piotroski F-Score | 7 |